74
Participants
Start Date
May 25, 2024
Primary Completion Date
October 30, 2025
Study Completion Date
October 30, 2027
Paclitaxel
"First-line chemotherapy regimen:~* Paclitaxel: 175 mg/m², intravenous infusion, on day 1.~* Carboplatin: AUC 5, intravenous infusion, on day 1.~* Surufatinib:250 mg once daily, taken continuously.~Maintenance Therapy Regimen:~* Surufatinib: 250 mg once daily, taken continuously.~* Olaparib: 300 mg twice daily."
RECRUITING
Anhui Cancer Hospital, Hefei
Hutchison Medipharma Limited
INDUSTRY
Anhui Provincial Cancer Hospital
OTHER